Company
Verastem, Inc. (VSTM)
Standardized SEC financial data for Verastem, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001526119 · NASDAQ · Pharmaceutical Preparations.
Gross margin
85.9%
Operating margin
-550.3%
Net margin
-677.6%
Revenue growth (YoY)
209.1%
Return on equity
-366.2%
Free cash flow
-$137.5M
Debt / equity
0.71×
Current ratio
3.09×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $88.5M | $2.1M | $2.6M | — | $10.0M | $30.9M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $147.5M | $100.3M | $87.9M | $79.1M | $89.1M | $205.2M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$33.5M | -$53.5M | -$63.7M | -$86.5M | -$104.8M | -$137.5M |
| Capital expenditures |
Get VSTM data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VSTM/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VSTM/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"